These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2385410)

  • 1. Cholesterol lowering drugs.
    Amarasingham R
    N Z Med J; 1990 Aug; 103(895):380. PubMed ID: 2385410
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
    Islami Y; Ribeiro LG
    Arq Bras Cardiol; 1988 Jul; 51(1):43-8. PubMed ID: 3073735
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hyperlipidaemias. Current avenues and new horizons.
    Janus ED
    Aust Fam Physician; 1989 Sep; 18(9):1071-4, 1078-83, 1086. PubMed ID: 2590074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering cholesterol in patients with coronary heart disease: are we ready yet?
    Barrett-Connor E
    Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875
    [No Abstract]   [Full Text] [Related]  

  • 6. Choice of lipid-lowering drugs.
    Med Lett Drugs Ther; 1998 Dec; 40(1042):117-22. PubMed ID: 9884672
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM; Katyal A
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of lipid-lowering drugs.
    Med Lett Drugs Ther; 1996 Aug; 38(980):67-70. PubMed ID: 8692076
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1980 Aug; 22(16):65-6. PubMed ID: 7402175
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 11. Diet and coronary heart disease.
    Med Lett Drugs Ther; 1985 Jan; 27(678):1. PubMed ID: 3965920
    [No Abstract]   [Full Text] [Related]  

  • 12. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    Krüger B
    Int J Clin Pharmacol Res; 1994; 14(5-6):177-83. PubMed ID: 7672874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1985 Aug; 27(695):74-6. PubMed ID: 3860714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of coronary heart disease with diet and lipid-reducing agents].
    Sailer D; Kolb S
    Fortschr Med; 1982 Nov; 100(43):2005-10. PubMed ID: 7152437
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal age for starting lipid lowering treatment. A 10 year risk of 30% should be used.
    Simpson WG; Twomey P
    BMJ; 2000 Sep; 321(7261):637; author reply 638. PubMed ID: 11023327
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of a patient with a null low-density lipoprotein receptor mutation: a case report.
    Kolovou GD; Dedoussis GV; Anagnostopoulou KK; Hatzigeorgiou GCh; Salpea KD; Choumerianou DM; Rammos S; Mikhailidis DP; Cokkinos DV
    Angiology; 2006 Dec-2007 Jan; 57(6):729-32. PubMed ID: 17235114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National service framework for coronary heart disease. Target of lowering cholesterol by 30% needs to be justified.
    Cracknell P
    BMJ; 2000 Sep; 321(7261):634. PubMed ID: 11023319
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
    Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
    [No Abstract]   [Full Text] [Related]  

  • 20. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.